柔性变截面滑移式机械手的控制

研究了柔性变截面滑移式机械手臂的控制。首先，基于有限元法导出系统的动力学方程，然后分别建立了两种控制方式的状态方程：１）以加速度和角加速度作为控制变量：２）以力和力矩作为控制变量。控制过程分为“粗控”和“精控”两步进行。“精控”过程采用线性二次型高斯控制。最后给出了数值模拟的结果。     

二柱掩护式支架承载能力区理论的研究

本文以二柱掩护式支架为例.建立了支架承载能力区的理论.并以此理论为基础.通过计算机模拟分析的方法.探讨了影响支架承载能力区的诸因素.使得定量计算支架承载能力成为可能.完善和发展了支架力平衡区的理论。     

Si1－xGex/Si量子阱发光材料的分子束外延生长及其结构研究

采用固源Si分子束外延,在较高的生长温度于Si(100)衬底上制备出Si1－xGex/Si量子阱发光材料。发光样品的质量和特性通过卢瑟福背散射、X射线双晶衍射及光致发光评估。背散射实验中观察到应变超晶格的反常沟道效应;X射线分析表明材料的生长是共度的、无应力释放的,结晶完整性好。低温光致发光主要是外延合金量子阱中带边激子的无声发射和横光学声子参与的激子复合。并讨论了生长温度对量于阱发光的影响。     

Numerical investigation of confined swirling gas-solid two phase jet

This paper presents a k-e-kp multi-fluid model for simulating confined swirling gas-solid two phase jet comprised of particle-laden flow from a center tube and a swirling air stream entering the test section from the coaxial annular. A series of numerical simulations of the two-phase flow of 30μm, 45μm, 60μm diameter particles respectively yielded results fitting well with published experimental data.     

有机分子螺旋结构的确定和三维表示

为了正确地判定有机化合物分子的螺旋结构并进行直观地描述，进而有效地分析其螺旋结构和光学活性的关系，根据立体化学的原理，提出了一种易于操作的判定有机化合物分子螺旋结构的方法，并用分子模型建造软件Weblab－ViewerPro.4.2作为工具，给出了一种分子螺旋结构三维图形表示的新方式。通过实例介绍了存在多条螺旋线的复杂有机分子的三维模型。结果表明，文中提出的方法，将有益于进一步完善和推广有机分子的螺旋结构理论。     

Effect of Notoginsenoside-Rg1 on the Expression of Several Proteins in the Striatum of Rat Models with Parkinson＇s Disease

After establishing hemi-Parkinsonian rat models, the relationships between neuron death and the expression of several proteins, such as c-Fos, GFAP, GDNF, NF-κB and some cytokines were determined. Therapeutics experiments with notoginsenoside-Rg1 were carried out. The research results show that the expressions of GFAP, NF-Kκ and c-Fos will obviously increase in the lesion side of the striatum and the expression of GDNF will decrease, which implies that the signal transduction pathway may participate in the apoptosis in neurons. The levels of some cytokines such as TNF-α, IL-1β in the striatum of PD rat models increased compared to those of normal rats. The results of the therapeutics experiments show that notoginsenoside-Rg1 may repress the immune inflammation response and regulate the immune function through the neuro-immune molecular network. Therefore, notoginsenoside-Rg1 can be used as an effective drug for anti-oxidation and anti-inflammation, and can be used in the therapy of Parkinson＇s disease（PD）.